Group One Trading’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-300
Closed -$6.46K 8423
2025
Q2
$6.46K Buy
+300
New +$6.76K ﹤0.01% 6967
2025
Q1
Sell
-2,000
Closed -$51.9K 7609
2024
Q4
$51.9K Buy
+2,000
New +$49.8K ﹤0.01% 5027
2024
Q1
Sell
-200
Closed -$3.25K 7063
2023
Q4
$3.25K Hold
200
﹤0.01% 6675
2023
Q3
$2.76K Buy
200
+100
+100% +$1.58K ﹤0.01% 6940
2023
Q2
$2.21K Buy
+100
New +$2.11K ﹤0.01% 7057
2022
Q1
Sell
-25,200
Closed -$939K 8032
2021
Q4
$939K Buy
25,200
+25,100
+25,100% +$1.08M ﹤0.01% 3422
2021
Q3
$4K Buy
+100
New +$4.82K ﹤0.01% 7795
2021
Q2
Sell
-300
Closed -$11K 8145
2021
Q1
$11K Buy
+300
New +$11.9K ﹤0.01% 7001
2020
Q1
Sell
-100
Closed -$2K 5262
2019
Q4
$2K Buy
+100
New +$1.63K ﹤0.01% 4881

Other funds holding BLFS

Group One Trading's BLFS Position: Q1 2022 in Review

Group One Trading sold out of BioLife Solutions (BLFS) in Q1 2022, closing a stake of 5,874 shares — an estimated $155K sold.

Group One Trading first reported a position in BLFS in Q1 2021 and held it in 4 quarters. The position peaked at $219K in Q4 2021. 164 funds tracked by Wall St. Rank hold BLFS as of Q1 2022.

  • Group One Trading reported no remaining BioLife Solutions position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 5,874 BioLife Solutions shares in Q1 2022, an estimated $155K.
  • Group One Trading first reported a position in BioLife Solutions in Q1 2021 and held it in 4 quarters.
  • Group One Trading's BioLife Solutions position peaked at $219K in Q4 2021.
  • 164 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.